For: Primary Care Providers who want to improve the success of their MOUD treatment program, increase treatment plan adherence, reduce program drop outs and reduce missed appointments.
For: Emergency and acute care departments who want to improve the successful transition of their patients to out patient care and reduce hospital readmissions
For: Residential or intensive outpatient treatment programs that want to improve post treatment care and long-term success of their patients recovery
For: Justice Teams who want to reduce revocation and recidivism and improve the success rate of their probation and reentry programs
Improves Patient Engagement
Patient Portals (SUD)
Q2i’s Patient Mobile App
Increases Patient Adherence to Treatment Plan*
National MAT Average
Q2i’s OARS Technology
* Based on Urine Toxicology Results (Opioid Negative)
I just got right into it. It was pretty self-explanatory. It was one of the easiest apps I've used.
My patients seem to really like it. It was very easy to use. I think it was just a positive experience.
I think it helped being able to connect with the patient more than just at their appointments.
It was good. It helped me relieve a lot of my stress and frustrations and it helped me communicate with my doctor a little better.
It was just easier to keep track of everything, and especially with the color coding. And it's easier to be in contact with the patients.
Results Using Q2i Technology
Improves Patient Engagement
- Patient Portals (SUD) 11.2%
- Q2i’s Patient Mobile App 85%
Increases Patient Adherence to Treatment Plan*
- National MAT Average 50%
- Q2i’s OARS Technology 92%
* Based on Urine Toxicology Results (Opioid Negative)
%
Extra Provider Revenue
Missed appointments lead to lost revenue for providers. Patients using OARS attend more appointments than the national average for MAT patients by >32%.
NIH/UCLA Phase 1 Responses
Technology Improving Medication-Assisted Treatment in Primary Care
A recent study of OARS in a primary care setting found that both primary care providers and MOUD patients felt that:
- OARS is easy to use
- OARS improves patient-provider communication
- OARS improves patient engagement in treatment
Ease of Use
Provider Feedback
Very user friendly I have to say. Like really, it was very simple to navigate, I am not IT savvy at all. If I tell you it was easy, it was easy
My patients seem to really like it. It was very easy to use. I think it was just a positive experience.
It was easy, user friendly, very easy to adapt with.
It’s easy to use, it’s very user friendly. And I liked the color coding.
Patient Feedback
I think it’s very easy. Nobody really had to explain anything. They just had to set it up and I was able to use it
I just got right into it. It was pretty self-explanatory. It was one of the easiest apps I’ve used.
Yeah, it was so simple to use. Everything’s right there big on the homepage. So, it’s like you don’t have to go to a menu and then search or scroll. It’s like everything was right there.
I had no problem at all. A new person that never used the portal before would be able to use it. It’s real easy and self-explanatory
Communication
Provider Feedback
I think it helped being able to connect with the patient more than just at their appointments.
What I really liked is how I knew what was going on in my patient’s life. I feel like it allowed me to give more informed care
It can help bridge that gap where you can have more communication with the patient and they can readily assess the information.
Patient Feedback
I think that with the OARS app, I have a better relationship, a patient-doctor relationship, where my doctor has a better understanding of who I am, where I’m at, and why I’m in this state that I’m in with everything that’s going on. I think it changed it dramatically in a very, very positive way.
It makes it much more convenient. I don’t feel like I’m hoping for a call back. I know she got my message and I know that she’s going to get back to me. It gives me more confidence that the communication is going to occur.
It was good. It helped me relieve a lot of my stress and frustrations and it helped me communicate with my doctor a little better.
I think it made my interactions with my doctor a lot better, because you feel that connectivity to them number one, when you have the app. And then also you’re more self-aware while you’re using the app.
Engagement
Provider Feedback
It gave a more holistic approach. You can see all aspects of their treatment and see like how compliant they are in all aspects.
It was just easier to keep track of everything, and especially with the color coding. And it’s easier to be in contact with the patients.
I think at a glance, it could help to organize the information, the data regarding patient care, which can impact the decision making.
Patient Feedback
I really like the journaling. I really enjoy that part because it gives me a more sense of what’s going on with myself. But it’s not even just about me, but it gives my doctor a chance to kind of see what’s going on with me when I might see her once a month and you try to tell somebody what’s going on in that timeframe and it’s kind of hard
Anything that makes managing opioid dependence easier, I am all for. I highly recommend this app for doing that. The one thing that is left out of opioid dependency management a lot is the humanity in it. And this allows more convenience for the patient rather than being demanding of the patient. And I think that’s a really big deal
It was good because it made me figure out that I might not be at the right dosage and that certain journal entries provoked thought about maybe I was needing to get more medications, so I think it was extremely helpful
If you can look back through your journaling, and if you look back through your urines and everything, and you see that you’re maybe messing up in some places, you can look back on that and see what in your life is going on that’s making you do these things and just reflect back on some things that you might see that you need to work on
100% Cloud, ready-to-go
Modern User Interface
Flexible and Scalable
HIPAA Compliant
Solutions
Opioid Addiction Recovery Support
For: Primary Care Providers who want to improve the success of their MOUD treatment program, increase treatment plan adherence, reduce program drop outs and reduce missed appointments.
OARS improves MOUD treatment. It provides improved connection, management and support of patients, especially between appointments. OARS provides risk of drop of indicators, Telehealth and many features that combine to improve MOUD treatment programs. It has been shown to increase engagement, adherence to treatment plan and reduce missed appointments. More >>
Opioid Addiction Recovery Support-CM
For: Emergency and acute care departments who want to improve the successful transition of their patients to out patient care and reduce hospital readmissions.
OARS–CM, based on our award wining OARS platform, it encompasses reward-based technology designed by Contingency Management experts at UCONN. It seamlessly calculates and then delivers rewards against targeted behaviors. It provides gamification to deliver high impact, extremely economical results with low burden for clinical staff while maintaining maximum fidelity. More >>
Continuing Alumni Support Application
For: residential or intensive outpatient treatment programs that want to improve post treatment care and long-term success of their patients recovery.
CASA provides the care team of a residential or intensive outpatient detox program with ongoing connection to their alumni. It supports and improves navigation back into the community and enables establishing a network of sober friends and tools to improve long-term recovery success. More >>
Probation And Reentry Coach Application
For: Justice Teams who want to reduce revocation and recidivism and improve the success rate of their probation and reentry programs.
Probation And Reentry Coach Application (patent pending) helps Justice Teams by increasing connection, insight and support for successful community supervision. It helps JIPs set goals and accomplish them by connecting them to local healthcare, SUD treatment, Employment, Housing and other services that help address the SDOH. More >>
About Q2i
Our Mission
Our mission is to design, develop, then supply the most advanced technologies that enable care teams to improve the success of their Substance Use Disorder treatment programs and interventions.
Our Vision
Our vision is to drive innovation in order to increase the availability, accessibility and success of treatment so that everyone seeking recovery from Substance Use Disorder can obtain the treatment they need in a manner both convenient and effective.
About
Q2i is a software as a service HealthTec company, specializing in developing applications that support recovery from OUD/SUD. Q2i was formed in 2016 as a result of the devastation occurring in our local communities caused by the opioid epidemic and to work to design technology that supports and improves recovery and help save lives.
Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.
Q2i develops technology that assists health care providers in achieving the IHI quadruple aim of improving the patient experience of care (including quality and satisfaction), improving the health of populations, reducing the per capita cost of health care and improved clinician experience.
Contingency Management
Contingency Management (CM) is a reward-based intervention built on the principles of operant conditioning to promote behavior change and reinforce positive behaviors. CM delivers tangible monetary-based rewards contingent upon targeted outcomes or behaviors.
CM has demonstrated efficacy for improving abstinence and other substance use disorder (SUD) treatment outcomes in a diverse range of treatment populations and settings.
Q2i has partnered with Dr. Sheila M. Alessi, Ph.D. from the University of Connecticut. Dr. Alessi and her colleagues at UConn are experts in the field of contingency management. Their goal is to bring CM techniques from research to practice to improve outcomes for OUD/SUD patients.
Difficulties with traditional CM programs include the requirement for intensive hands-on management and oversight to maintain program fidelity. This requires highly trained staff to manage supervision and additional staff to manage the backend operation, such as purchasing of rewards and accounting.
Q2i’s solutions overcome these difficulties by digitizing and automating traditional contingency management and seamlessly integrating it into the cutting-edge Opioid Addiction Recovery Support (OARS) technology. OARS with CM addresses all long-term sustainability challenges while maintaining program fidelity.
OARS with CM, a mobile technology-enabled contingency management program, is a significant scientific and clinical advancement to improve treatment for OUD, SUD, and MAT programs.
Easy, Secure Video Telehealth
OARS has in-built secure, encrypted, HIPAA-compliant Telehealth video. The Care Team can schedule and run one-to-one or group Telehealth sessions directly from their OARS dashboard. Patients can easily and conveniently access sessions from within their OARS mobile app. This keeps all their treatment support in one place and has the added benefits of the OARS calendar of appointments, and alerts for upcoming sessions, making them easy to manage.
Academic Partners/Clinical studies
NIH/National Institute of Drug Abuse funded clinical studies in progress with Q2i’s academic partners
Reward Based Technology to improve opioid use disorder treatment initiation after an ED visit
Increasing the demand and reach of effective Medication Assistance Treatment (MAT) for opioid use disorder (OUD) is critical to decreasing OUD associated morbidity, mortality, and economic consequences. The technology breakthrough to be studied in this project will give individuals with OUD access to a smartphone application designed to help support initiation and adherence with MAT treatment regimens through patient-oriented educational and monitoring features, as well as a new evidence-based reward function shown in other research to promote treatment adherence, improve abstinence, and improve other health outcomes. The intervention will aim to facilitate the entire treatment trajectory, starting with initial transition from an acute care setting to outpatient MAT initiation and continuing through successful transition to maintenance.
More info
NIH/NIDA Grant Number:
1R42DA049448-01
Technology Improving Medication-Assisted Treatment in Primary Care
With over 72,000 overdose deaths in 2017, of which 47,600 are attributable to opioid overdose, the opioid epidemic has become North America’s most widespread behavioral public health problem. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. The Opioid Addiction Recovery Support (OARS) comprises of a healthcare team portal connected to a patient mobile application, to provide opioid related education, promote connectedness with clinicians, and track MAT treatment progress. This STTR Fast Track proposal will conduct interviews with patients that will inform optimal design of OARS and utilize a “stepped wedge” effectiveness design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes in primary care settings and evaluate sustainability and return on investment.
NIH/NIDA Grant Number:
1R42DA050398-01
Digital Health Technology Improving Successful Reintegration of Recently Released Justice-Involved Individuals with Substance Use Disorders
Of the 2 million individuals that are confined nationwide 10,000 are released weekly with inadequate support solutions that comprehensively address social determinants of health resulting in a high recidivism rate. The lack of support can significantly affect health outcomes, especially for recently released justice-involved individuals with substance use disorder (SUD). Digital health technology can help recently released individuals navigate and adapt to their new environment. Technology makes it possible to provide localized support – such as access to location-specific information about risk reduction, housing, accessing medical care, SUD treatment programs and availability, and support groups – that is not available through traditional mechanisms. It transforms support services from fragmented, disparate services to centralized, one-stop shopping that is available 24/7 for people in need.
NIH/NIDA Grant Number:
1R41DA051156-01
Leadership Team
Steven Jenkins
CEO
Gerald A. Kraines, M.D.
CMO
Gerald A. Kraines, M.D. a faculty member at Harvard Medical School for over 30 years…
Tom Keen
Chief Technology Officer
Tom Keen has over 25 years of hands-on leadership experience in comprehensive organizational design, software product leadership and operations specifically in SaaS and mobile product development and operations.
Larry Klimczyk
Chief Revenue Officer
Larry Klimczyk has over 20 years’ experience launching enterprise-level Software as a Service (SaaS) mobile solutions around the globe.
Dominic Trupiano
Customer Success Officer
Medical Advisory Board
Q2i’s Medical Advisory Board provides in-depth subject matter expertise across a broad spectrum of healthcare delivery. This diverse composition provides a strong group dynamic providing insight and scientific direction. This ensures Q2i’s solutions not only improves patient outcomes and helps health systems and payers create value but that we go beyond traditional clinical efficacy to capture newer patient-focused considerations and impact the effectiveness and efficiency of care delivered under new value-based performance systems.
Sara M. Bolton
M.D.
Gary Chinman
M.D
Guy Slater
FRCS
Jeremy Vigneault
PT, MSPT, OCS, Cert. MDT
Jennifer Davenport
MD, MHA, FSCAI
P. Elizabeth Thomas
MD
Q2i in the News
July 20, 2021
Q2i’s reward-based digital technology moves to Phase II of National Institutes of Health (NIH) clinical trial to further evaluate the application’s efficacy in increasing treatment adherence for substance use disorder after an ED Visit.
Feb 25, 2021
Q2i’s OARS software application moves to Phase II of National Institute of Health (NIH) clinical trial which will evaluate the application’s efficacy in improving Opioid Use Disorder treatment
April 28, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Successful Community Reintegration of Recently Released Justice-Involved Individuals With Substance Use Disorders
Jan 7, 2020
Q2i Awarded NIH/NIDA Grant to Develop and Evaluate Digital Technology to Improve Medication-Assisted Treatment in Primary Care
Oct 17, 2019
Sept 4, 2019
Feb 6, 2019
Jan 8, 2019
Nov 15, 2018
Oct 9, 2018
Dec 29, 2017
Read more ›
Upcoming Events
Would you like to learn how Contingency Management can improve SUD Treatment initiation and retention? Q2i is proud to be participating in the 53rd annual American Society of Addition Medicine Conference. We will be featuring our evidence based research for OARS+CM, visit us in the exhibition hall at T-5. If you are not attending the event, we welcome the opportunity to learn more about your programs and personally share with you the results from our NIH/NIDA studies. Simply email us with a convenient time to talk.
Q2i will be exhibiting at ACA’s Winter 2022 Conference from January 6th – 9th
Q2i’s Management solutions will be on display at the American Correctional Associations Conference. For more information on the Conference click the link below.
View Event Details
Q2i will be exhibiting at the APPA 2022 Winter Training Institute from January 30th – February 2nd
Q2i’s Management solutions will be on display at the American Probation and Parole Association Conference. For more information on the Conference click the link below.
View Event Details
Contact Q2i
(P) 617.812.2602
1660 Soldiers Field Rd.
Brighton, MA 02135